The global COVID-19 crisis has fundamentally impacted the way we live our lives as well as the operation of the entire drug development community. During the early stages of the pandemic the Cmed leadership team has implemented a number of measures to ensure the safety of our employees, clients and partners, as well as ensuring the continued delivery of our CRO services and our encapsia clinical data system. Our goal has been to minimise the impact of COVID-19 on our business, our clients, investigator sites and patients.
Thank you for your continued loyalty and trust in Cmed and encapsia during these uncertain times. We are continuously monitoring the evolving circumstances surrounding the COVID-19 outbreak and continue to operate as normal. ~ Our highest priority is to maintain the health and safety of our people, customers, partners and suppliers while meeting our service commitments. Cmed has implemented a range of measures in line with World Health Organization guidance to minimise the risks for employees and customers.
Direct Data Capture (DDC) is one of the four types of eSource (see previous post), and is often what people first think of as eSource. Direct data capture is the process of entering data into the eCRF contemporaneously, rather than transcribing from other sources such as paper or site EHR systems. Some technology providers believe that EDC systems can be used as eSource, where the web based EDC system is carried around on a laptop, or potentially a tablet, and data is entered directly into this system.
eSource means different things to different people. You may have never even heard of it, so this is the first in a series of posts which aim to unlock what eSource is. When I ask “What does eSource mean to you?”, I receive many different answers, and quite often they weren’t what I had expected. Perhaps we should start by reminding ourselves of the current method for collecting and managing data in clinical trials.
Cmed Technology announces 20 years of clinical trial software provision and hosting with zero downtime. Encapsia is Cmed’s clinical data suite designed around a unified clinical database with user-centric apps to support all trial processes and a full cloud architecture. The inherent flexibility of this structure means mid study protocol amendments or technical system updates can be made with no disruption for users. In this respect, much of the knowledge and experience of Cmed’s previous technology platform, Timaeus, was applied to encapsia.
What a week in San Diego at DIA 2019! After arriving home late (or early Friday morning) and exhausted from the long journey, I still have an energy coursing through my veins fuelled by the week we left behind. As I reflect what the week meant for us, I feel an excitement about the future of both Encapsia and our industry. Having observed the conference themes and the offerings from other vendors, I can’t help but feel there is nothing quite like Encapsia.